(Q33851977)

29 July 2017

1 reference

title

Update on perinatal HIV transmission (English)

1 reference

29 July 2017

0 references

Fowler MG

1

1 reference

29 July 2017

Simonds RJ

series ordinal

2

1 reference

29 July 2017

Roongpisuthipong A

series ordinal

3

1 reference

29 July 2017

publication date

1 February 2000

1 reference

Pediatric Clinics of North America

29 July 2017

published in

1 reference

29 July 2017

volume

47

1 reference

29 July 2017

issue

1

1 reference

29 July 2017

page(s)

21-38

1 reference

Estimating the timing of mother-to-child transmission of human immunodeficiency virus in a breast-feeding population in Kinshasa, Zaire

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970193-0

Perinatal intervention trial in Africa: effect of a birth canal cleansing intervention to prevent HIV transmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970193-0

Prevention of simian immunodeficiency virus, SIVsm, or HIV-2 infection in cynomolgus monkeys by pre- and postexposure administration of BEA-005.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970193-0

Proposed definitions for in utero versus intrapartum transmission of HIV-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970193-0

Sexual behavior and injection drug use during pregnancy and vertical transmission of HIV-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970193-0

Influence of other maternal variables on the relationship between maternal virus load and mother-to-infant transmission of human immunodeficiency virus type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970193-0

Maternal HIV-1 viral load and vertical transmission of infection: the Ariel Project for the prevention of HIV transmission from mother to infant.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970193-0

A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970193-0

Timing of mother-to-child HIV-1 transmission and diagnosis of infection based on polymerase chain reaction in the neonatal period by a non-parametric method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970193-0

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970193-0

After AIDS clinical trial 076: the changing pattern of zidovudine use during pregnancy, and the subsequent reduction in the vertical transmission of human immunodeficiency virus in a cohort of infected women and their infants. Women and Infants Tran

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970193-0

Estimating the rate of mother-to-child transmission of HIV. Report of a workshop on methodological issues Ghent (Belgium), 17–20 February 1992

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970193-0

6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial. DITRAME Study G

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970193-0

Risk of human immunodeficiency virus type 1 transmission through breastfeeding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970193-0

The sensitivity of HIV-1 DNA polymerase chain reaction in the neonatal period and the relative contributions of intra-uterine and intra-partum transmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970193-0

Mother-to-child transmission of HIV: implications of variation in maternal infectivity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970193-0

Late postnatal mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970193-0

Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970193-0

Trends in human immunodeficiency virus (HIV) counseling, testing, and antiretroviral treatment of HIV-infected women and perinatal transmission in North Carolina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970193-0

Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970193-0

Population-based study of fertility in women with HIV-1 infection in Uganda

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970193-0

Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970193-0

The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1--a meta-analysis of 15 prospective cohort studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970193-0

Defining the time of fetal or perinatal acquisition of human immunodeficiency virus type 1 infection on the basis of age at first positive culture. Women and Infants Transmission Study (WITS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970193-0

Prevention of vertical HIV transmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970193-0

Distinct risk factors for intrauterine and intrapartum human immunodeficiency virus transmission and consequences for disease progression in infected children. Perinatal AIDS Collaborative Transmission Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970193-0

Mother-to-child transmission of HIV-1 in Congo, central Africa. Congolese Research Group on Mother-to-Child Transmission of HIV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970193-0

Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother to child. The Women and Infants Transmission Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970193-0

Excess intrauterine fetal demise associated with maternal human immunodeficiency virus infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970193-0

International multicentre pooled analysis of late postnatal mother-to-child transmission of HIV-1 infection. Ghent International Working Group on Mother-to-Child Transmission of HIV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970193-0

Trends in perinatal transmission of HIV/AIDS in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970193-0

Antiretroviral therapies in pregnancy: maternal, fetal and neonatal effects. Swiss HIV Cohort Study, the Swiss Collaborative HIV and Pregnancy Study, and the Swiss Neonatal HIV Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970193-0

Potential risk factors for vertical HIV-1 transmission in Catalonia, Spain: the protective role of cesarean section. The Working Group on HIV-1 Vertical Transmission in Catalonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970193-0

Obstetric factors and mother-to-child transmission of human immunodeficiency virus type 1: the French perinatal cohorts. SEROGEST French Pediatric HIV Infection Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970193-0

Perinatal HIV-1 transmission: interaction between zidovudine prophylaxis and mode of delivery in the French Perinatal Cohort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970193-0

Hormonal contraception, sexually transmitted diseases, and risk of heterosexual transmission of human immunodeficiency virus type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970193-0

Heterosexual behavior during pregnancy and perinatal transmission of HIV-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970193-0

Acceptability and impact of zidovudine for prevention of mother-to-child human immunodeficiency virus-1 transmission in France

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970193-0

Mother-child class I HLA concordance increases perinatal human immunodeficiency virus type 1 transmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970193-0

HIV transmission through breastfeeding: a study in Malawi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970193-0

Maternal viral load and timing of mother-to-child HIV transmission, Bangkok, Thailand. Bangkok Collaborative Perinatal HIV Transmission Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970193-0

Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970193-0

Thymic dysfunction and time of infection predict mortality in human immunodeficiency virus-infected infants. CDC Perinatal AIDS Collaborative Transmission Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970193-0

Human Immunodeficiency Virus Type 1-Infected Cells in Breast Milk: Association with Immunosuppression and Vitamin A Deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970193-0

Studies of human immunodeficiency virus type 1 mucosal viral shedding and transmission in Kenya

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970193-0

Maternal immunologic and virologic risk factors for infant human immunodeficiency virus type 1 infection: findings from the Women and Infants Transmission Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970193-0

Association of maternal drug use during pregnancy with maternal HIV culture positivity and perinatal HIV transmission.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970193-0

Estimated timing of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission by use of a Markov model. The HIV Infection in Newborns French Collaborative Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970193-0

Maternal vitamin A deficiency and mother-to-child transmission of HIV-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970193-0

Human immunodeficiency virus load in breast milk, mastitis, and mother-to-child transmission of human immunodeficiency virus type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970193-0

Maternal virus load and perinatal human immunodeficiency virus type 1 subtype E transmission, Thailand. Bangkok Collaborative Perinatal HIV Transmission Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970193-0

Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970193-0

Efficacy of zidovudine and human immunodeficiency virus (HIV) hyperimmune immunoglobulin for reducing perinatal HIV transmission from HIV-infected women with advanced disease: results of Pediatric AIDS Clinical Trials Group protocol 185.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970193-0

Infant feeding and risk of mother-to-child transmission of HIV-1 in São Paulo State, Brazil. São Paulo Collaborative Study for Vertical Transmission of HIV-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970193-0

Mode of delivery and gestational age influence perinatal HIV-1 transmission. Italian Register for HIV Infection in Children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970193-0

Infective and anti-infective properties of breastmilk from HIV-1-infected women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970193-0

Transmission of human immunodeficiency virus type 1 through breast-feeding: how can it be prevented?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970193-0

The Ariel Project: A prospective cohort study of maternal-child transmission of human immunodeficiency virus type 1 in the era of maternal antiretroviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970193-0

Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970193-0

Secretory leukocyte protease inhibitor (SLPI) in mucosal fluids inhibits HIV-I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970193-0

Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire: a randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970193-0

Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970193-0

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0031-3955(05)70193-0

1 reference

29 July 2017

1 reference